Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro

International Journal of Pharmaceutics

Volumn 185, Issue 1, 1999, Pages 93-101

  Matsumoto, Junko ^a   Nakada, Yuichiro ^a   Sakurai, Kazuo ^a   Nakamura, Tomomi ^a   Takahashi, Yoshiteru ^a  

^a KANEBO LTD   (Japan)

Author keywords

Fractionation; In vitro; Nanoparticles; Poly(ethylene glycol); Poly(L lactide); Progesterone; Release; Triblock copolymer

Indexed keywords

COPOLYMER; MACROGOL; NANOPARTICLE; POLYLACTIDE; POLYSORBATE 80; PROGESTERONE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; EVAPORATION; FRACTIONATION; MOLECULAR WEIGHT; POLYMERIZATION; PRIORITY JOURNAL;

BIOCOMPATIBLE MATERIALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; HUMANS; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; POLYMERS; PROGESTERONE;

EID: 0032815462     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00153-2     Document Type: Article

References (13)

1. Bazile D., Prudhomme C., Bassoullet M., Marlard M., Spenlehauer G., Veillard M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84:1995;493-498.
2. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263:1994;1600-1603.
3. Illum L., Davis S.S. The organ uptake of intravenously administered colloidal particles can be altered using nonionic surfactant (poloxamer 338). FEBS Lett. 167:1984;70-82.
4. Leenslag J.W., Pennings A.J. Synthesis of high-molecular-weight poly(L-lactide) initiated with tin 2-ethylhexanoate. Makromol. Chem. 188:1987;1809-1814.
5. Müller R.H., Walis K.H., Troster S.D., Kreuter J. In vitro characterization of poly(methyl-methacrylate) nanospheres and correlation to their in vivo fate. J. Control. Release. 20:1992;237-246.
6. Nakada Y., Sakurai K., Horiushi M., Tudomi R., Nakamura T., Takahashi Y. Long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(L-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks. Pharm. Sci. 3:1997;1-4.
7. Niwa T., Takeuchi H., Hino T., Kunou N., Kawashima Y. Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behavior. J. Control. Release. 25:1993;89-98.
8. Ogawa Y., Okada H., Yamamoto M., Shimamoto T. In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. Chem. Pharm. Bull. 36:1988;2576-2581.
9. Okada H., Doken Y., Ogawa Y., Toguchi H. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res. 11:1994;1143-1147.
10. Peracchia M.T., .Gref R., Minamitake Y., Domb A., Lotan N., Langer R. PEG coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulationand release characteristics. J. Control. Release. 46:1997;223-231.
11. Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylkene glycol)-coated vesicles. Biochim. Biophys. Acta. 1062:1991;77-82.
12. Stolnik S., Dunn S.E., Garnett M.C., Davies M.C., Coombes A.G.A., Taylor D.C., Irving M.P., Purkiss S.C., Tadros T.F., Davis S.S., Illum L. Surface modification of poly(L-lactide-co-glycolide) nanospheres by biodegradable poly(L-lactide)-poly(ethyleneglycol) copolymers. Pharm. Res. 11:1994;1800-1808.
13. Verrecchia T., Spenhauer G., Bazile D.V., Murry-Brelier A., Archimbaud Y., Veillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J. Control. Release. 36:1995;49-61.